Live Quote · OTCBMXXYHealthcare · Medical - Diagnostics & Research

bioMérieux S.A.

$8.10▲ 2.02%(+$0.16)

TickerSpark Score

62/100

▌ Mixed

84

Valuation

75

Profitability

25

Growth

96

Health

30

Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a BMXXY research report →

52-Week Range13% of range

Low

$7.12

Current

$8.10

High

$14.62

Company Overviewwww.biomerieux.com

About the company

bioMérieux S. A. is a global leader in the development and production of in vitro diagnostic solutions, primarily aimed at detecting infectious diseases.

CEO: Pierre Boulud
IPO: 2023
Employees: 14,147
HQ: Marcy l'Étoile, FR

Price Chart

-37.45% · this period

Valuation

Market Cap: $9.55B
P/E: 20.66
P/S: 2.02
P/B: 2.00
EV/EBITDA: 8.53
Div Yield: 1.41%

Profitability

Gross Margin: 53.07%
Op Margin: 9.54%
Net Margin: 9.76%
ROE: 9.89%
ROIC: 6.32%

Growth & Income

Revenue: $4.07B · 2.26%
Net Income: $381.81M · -11.66%
EPS: $0.32 · -11.99%
Op Income: $694.70M
FCF YoY: 35.34%

Performance & Tape

52W High: $14.62
52W Low: $7.12
50D MA: $8.25
200D MA: $12.20
Beta: 0.57
Avg Volume: 2.17K

Get TickerSpark's AI analysis on BMXXY

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Coverage · BMXXY